As of Oct 02
| +0.64 / +7.93%|
The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 23.00, with a high estimate of 26.00 and a low estimate of 20.00. The median estimate represents a +164.06% increase from the last price of 8.71.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.